Trial Profile
Clinical Trials Insight: 700028322
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2007
Price :
$35
*
At a glance
- Drugs IPH 1101 (Primary) ; Antineoplastics
- Indications Solid tumours
- Focus Therapeutic Use
- Sponsors Innate Pharma
- 09 Nov 2007 New trial record.